For example, EVs derived from mesenchymal stem cells exert protective immunomodulatory effects through the release of IL-10, a crucial anti-inflammatory mediator, both in vitro and in mouse models of bacterial-induced sepsis [160], so that sepsis-associated acute kidney injury (SA-AKI) can be alleviated and treated. Here, IL10 is linked to Sepsis.